NFE2L2 and non-small cell lung carcinoma: investigated the role of Nrf2 and Keap1 in non‐small‐cell lung carcinoma (NSCLC) and found that abnormal Nrf2 and Keap1 expression was associated with worse overall survival in NSCLC patients 11.